Zhang W, Feng L-J, Teng F, Li Y-H, Zhang X, Ran Y-G (2020) Incidence and risk of proteinuria associated with newly approved vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: an up-to-date meta-analysis of randomized controlled trials. Expert Rev Clin Pharmacol 13:311–320

Article  PubMed  Google Scholar 

Semeniuk-Wojtaś A, Lubas A, Stec R, Szczylik C, Niemczyk S (2016) Influence of tyrosine kinase inhibitors on hypertension and nephrotoxicity in metastatic renal cell cancer patients. Int J Mol Sci 17:2073

Article  PubMed  PubMed Central  Google Scholar 

Abbas A, Mirza MM, Ganti AK, Tendulkar K (2015) Renal toxicities of targeted therapies. Target Oncol 10:487–499

Article  PubMed  Google Scholar 

Shibuya M (2014) VEGF-VEGFR signals in health and disease. Biomol Ther (Seoul) 22:1–9

Article  PubMed  CAS  Google Scholar 

Izzedine H, Mangier M, Ory V, Zhang S-Y, Sendeyo K, Bouachi K et al (2014) Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy. Kidney Int 85:457–470

Article  PubMed  CAS  Google Scholar 

Calizo RC, Bhattacharya S, van Hasselt JGC, Wei C, Wong JS, Wiener RJ et al (2019) Disruption of podocyte cytoskeletal biomechanics by dasatinib leads to nephrotoxicity. Nat Commun 10:2061

Article  PubMed  PubMed Central  Google Scholar 

Penn JS, Madan A, Caldwell RB, Bartoli M, Caldwell RW, Hartnett ME (2008) Vascular endothelial growth factor in eye disease. Prog Retin Eye Res 27:331–371

Article  PubMed  PubMed Central  CAS  Google Scholar 

Al-Kharashi AS (2018) Role of oxidative stress, inflammation, hypoxia and angiogenesis in the development of diabetic retinopathy. Saudi J Ophthalmol 32:318–323

Article  PubMed  PubMed Central  Google Scholar 

Ahuja S, Saxena S, Akduman L, Meyer CH, Kruzliak P, Khanna VK (2019) Serum vascular endothelial growth factor is a biomolecular biomarker of severity of diabetic retinopathy. Int J Retina Vitreous 5:29

Article  PubMed  PubMed Central  Google Scholar 

Stewart MW (2012) The expanding role of vascular endothelial growth factor inhibitors in ophthalmology. Mayo Clin Proc 87:77–88

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cornel S, Adriana ID, Mihaela TC, Speranta S, Algerino DS, Mehdi B et al (2015) Anti-vascular endothelial growth factor indications in ocular disease. Rom J Ophthalmol 59:235–242

PubMed  PubMed Central  Google Scholar 

Hanna RM, Barsoum M, Arman F, Selamet U, Hasnain H, Kurtz I (2019) Nephrotoxicity induced by intravitreal vascular endothelial growth factor inhibitors: emerging evidence. Kidney Int 96:572–580

Article  PubMed  CAS  Google Scholar 

Phadke G, Hanna RM, Ferrey A, Torres EA, Singla A, Kaushal A et al (2021) Review of intravitreal VEGF inhibitor toxicity and report of collapsing FSGS with TMA in a patient with age-related macular degeneration. Clin Kidney J 14:2158–2165

Article  PubMed  PubMed Central  Google Scholar 

Shye M, Hanna RM, Patel SS, Tram-Tran N, Hou J, Mccannel C et al (2020) Worsening proteinuria and renal function after intravitreal vascular endothelial growth factor blockade for diabetic proliferative retinopathy. Clin Kidney J 13:969–980

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hanna RM, Ahdoot RS, Kim MS, Jhaveri KD, Kalantar-Zadeh K, Kurtz IB (2022) Intravitreal vascular endothelial growth factors hypertension, proteinuria, and renal injury: a concise review. Curr Opin Nephrol Hypertens 31:47–56

Article  PubMed  CAS  Google Scholar 

Hanna RM, Lopez EA, Hasnain H, Selamet U, Wilson J, Youssef PN et al (2019) Three patients with injection of intravitreal vascular endothelial growth factor inhibitors and subsequent exacerbation of chronic proteinuria and hypertension. Clin Kidney J 12:92–100

Article  PubMed  CAS  Google Scholar 

Schrijvers BF, Flyvbjerg A, De Vriese AS (2004) The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int 65:2003–2017

Article  PubMed  CAS  Google Scholar 

Ollero M, Sahali D (2015) Inhibition of the VEGF signalling pathway and glomerular disorders. Nephrol Dial Transplant 30:1449–1455

Article  PubMed  CAS  Google Scholar 

Guise E, Chade AR (2018) VEGF therapy for the kidney: emerging strategies. Am J Physiol-Renal Physiol 315:F747–F751

Article  PubMed  PubMed Central  CAS  Google Scholar 

Eremina V, Baelde HJ, Quaggin SE (2007) Role of the VEGF–a signaling pathway in the glomerulus: evidence for crosstalk between components of the glomerular filtration barrier. Nephron Physiol 106:p32–p37

Article  PubMed  CAS  Google Scholar 

Müller-Deile J, Worthmann K, Saleem M, Tossidou I, Haller H, Schiffer M (2009) The balance of autocrine VEGF-A and VEGF-C determines podocyte survival. Am J Physiol Renal Physiol 297:F1656–F1667

Article  PubMed  Google Scholar 

Sivaskandarajah GA, Jeansson M, Maezawa Y, Eremina V, Baelde HJ, Quaggin SE (2012) Vegfa protects the glomerular microvasculature in diabetes. Diabetes 61:2958–2966

Article  PubMed  PubMed Central  CAS  Google Scholar 

Tanabe K, Wada J, Sato Y (2020) Targeting angiogenesis and lymphangiogenesis in kidney disease. Nat Rev Nephrol 16:289–303

Article  PubMed  CAS  Google Scholar 

Leonard EC, Friedrich JL, Basile DP (2008) VEGF-121 preserves renal microvessel structure and ameliorates secondary renal disease following acute kidney injury. Am J Physiol Renal Physiol 295:F1648–F1657

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kang D-H, Hughes J, Mazzali M, Schreiner GF, Johnson RJ (2001) Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol 12:1448–1457

Article  PubMed  CAS  Google Scholar 

Chade AR (2016) Vascular endothelial growth factor therapy for the kidney: are we there yet? J Am Soc Nephrol 27:1–3

Article  PubMed  CAS  Google Scholar 

Logue OC, McGowan JWD, George EM, Bidwell GL (2016) Therapeutic angiogenesis by vascular endothelial growth factor supplementation for treatment of renal disease. Curr Opin Nephrol Hypertens 25:404–409

Article  PubMed  PubMed Central  CAS  Google Scholar 

Suga S-I, Kim Y-G, Joly A, Puchacz E, Kang D-H, Jefferson JA et al (2001) Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy. Kidney Int 60:1297–1308

Article  PubMed  CAS  Google Scholar 

Kang D-H, Hughes J, Mazzali M, Schreiner GF, Johnson RJ (2001) Impaired angiogenesis in the remnant kidney model. J Am Soc Nephrol 12:1448–1457

Article  PubMed  CAS  Google Scholar 

Kang D-H, Kim Y-G, Andoh TF, Gordon KL, Suga S-I, Mazzali M et al (2001) Post-cyclosporine-mediated hypertension and nephropathy: amelioration by vascular endothelial growth factor. Am J Physiol-Renal Physiol 280:F727–F736

Article  PubMed